Age-Related Macular Degeneration and its Current Treatment Strategies: An Updated Review

Author:

Gelat Brijesh,Trivedi Krupali,Malaviya Pooja,Rathaur Pooja,Patel Binita,Gelat Rahul,Johar Kaid

Abstract

The retinal pigment epithelium (RPE), which is crucial for good vision, supports the health and function of photoreceptors or Bruch’s membrane (BM). The two most prevalent retinal vascular disorders that account for the majority of blindness in people in their working years and older are diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). The blood-retinal barrier (BRB), cell differentiation, autophagy, growth factors (GFs), and other complex signaling pathways all play a role in maintaining morphology, and their disruption by harmful substances affects RPE function. It is urgent to gain a better understanding of the molecular mechanisms underlying the pathogenesis of AMD and identify potential targets as leads for creating potent therapies because there are currently no effective treatments for the early-AMD and late-AMD forms of the disease. For this reason, it is vital to identify molecular targets and therapies that can stop RPE deterioration in AMD and restore RPE function. Currently, the first-line treatment for nAMD and DME involves anti-vascular endothelial growth factor (VEGF) medications that inhibit VEGF family ligands, such as ranibizumab, bevacizumab (off-label usage), brolucizumab, and aflibercept. However, because nAMD and DME have complicated pathophysiological backgrounds, further research is still needed to determine the causes of non-response, resistance to anti-VEGF treatment, and disease relapses.

Publisher

IntechOpen

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3